Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 183

1.

Current trends in non-HDL cholesterol and LDL cholesterol levels in adults with atherosclerotic cardiovascular disease.

Vega GL, Grundy SM.

J Clin Lipidol. 2019 May 27. pii: S1933-2874(19)30188-6. doi: 10.1016/j.jacl.2019.05.012. [Epub ahead of print]

2.

Metabolic syndrome is a sequela of radiation exposure in hypothalamic obesity among survivors of childhood brain tumors.

Cooksey R, Wu SY, Klesse L, Oden JD, Bland RE, Hodges JC, Gargan L, Vega GL, Bowers DC.

J Investig Med. 2019 Feb;67(2):295-302. doi: 10.1136/jim-2018-000911. Epub 2018 Dec 9.

PMID:
30530528
3.

The association of cardiorespiratory fitness, body mass index, and age with testosterone levels at screening of healthy men undergoing preventive medical examinations: The Cooper Center Longitudinal Study.

DeFina LF, Radford NB, Leonard D, Wilson RK, Cooper TC, Clark SM, Willis BL, Vega GL, Barlow CE, Farrell SW, Gibbons LW, Yildiz BO, Gruntmanis U.

Maturitas. 2018 Dec;118:1-6. doi: 10.1016/j.maturitas.2018.09.004. Epub 2018 Sep 29.

PMID:
30415749
4.

Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study.

Neeland IJ, Singh S, McGuire DK, Vega GL, Roddy T, Reilly DF, Castro-Perez J, Kozlitina J, Scherer PE.

Diabetologia. 2018 Dec;61(12):2570-2579. doi: 10.1007/s00125-018-4720-1. Epub 2018 Aug 29.

PMID:
30159588
5.

Upper body fat predicts metabolic syndrome similarly in men and women.

Grundy SM, Williams C, Vega GL.

Eur J Clin Invest. 2018 Jul;48(7):e12941. doi: 10.1111/eci.12941. Epub 2018 May 15.

6.

Metabolic Concomitants of Obese and Nonobese Women With Features of Polycystic Ovarian Syndrome.

Boumosleh JM, Grundy SM, Phan J, Neeland IJ, Chang A, Vega GL.

J Endocr Soc. 2017 Nov 2;1(12):1417-1427. doi: 10.1210/js.2017-00323. eCollection 2017 Dec 1.

7.

Moderate to High Levels of Cardiorespiratory Fitness Attenuate the Effects of Triglyceride to High-Density Lipoprotein Cholesterol Ratio on Coronary Heart Disease Mortality in Men.

Farrell SW, Finley CE, Barlow CE, Willis BL, DeFina LF, Haskell WL, Vega GL.

Mayo Clin Proc. 2017 Dec;92(12):1763-1771. doi: 10.1016/j.mayocp.2017.08.015. Epub 2017 Nov 17.

PMID:
29157534
8.

Orthorexia Nervosa and Eating Disorder Symptoms in Registered Dietitian Nutritionists in the United States.

Tremelling K, Sandon L, Vega GL, McAdams CJ.

J Acad Nutr Diet. 2017 Oct;117(10):1612-1617. doi: 10.1016/j.jand.2017.05.001. Epub 2017 Jun 15.

9.

An Analysis of Individual Body Fat Depots and Risk of Developing Cancer: Insights From the Dallas Heart Study.

Gupta A, Pandey A, Ayers C, Beg MS, Lakoski SG, Vega GL, Grundy SM, Johnson DH, Neeland IJ.

Mayo Clin Proc. 2017 Apr;92(4):536-543. doi: 10.1016/j.mayocp.2016.12.023. Epub 2017 Mar 11.

10.

Association of triglyceride-to-high density lipoprotein cholesterol ratio to cardiorespiratory fitness in men.

Vega GL, Grundy SM, Barlow CE, Leonard D, Willis BL, DeFina LF, Farrell SW.

J Clin Lipidol. 2016 Nov - Dec;10(6):1414-1422.e1. doi: 10.1016/j.jacl.2016.09.008. Epub 2016 Sep 17.

11.

Comparison of visceral fat mass measurement by dual-X-ray absorptiometry and magnetic resonance imaging in a multiethnic cohort: the Dallas Heart Study.

Neeland IJ, Grundy SM, Li X, Adams-Huet B, Vega GL.

Nutr Diabetes. 2016 Jul 18;6(7):e221. doi: 10.1038/nutd.2016.28.

12.

Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy.

Srivastava A, Adams-Huet B, Vega GL, Toto RD.

J Investig Med. 2016 Aug;64(6):1102-8. doi: 10.1136/jim-2016-000102. Epub 2016 Jul 7.

13.

Fatty acid oxidation in normotriglyceridemic men.

Benjamin B, Wada Y, Grundy SM, Szuszkiewicz-Garcia M, Vega GL.

J Clin Lipidol. 2016 Mar-Apr;10(2):283-8. doi: 10.1016/j.jacl.2015.11.018. Epub 2015 Dec 2.

14.

Body fat distribution and incident cardiovascular disease in obese adults.

Neeland IJ, Turer AT, Ayers CR, Berry JD, Rohatgi A, Das SR, Khera A, Vega GL, McGuire DK, Grundy SM, de Lemos JA.

J Am Coll Cardiol. 2015 May 19;65(19):2150-1. doi: 10.1016/j.jacc.2015.01.061. No abstract available.

15.

Is non-high-density lipoprotein cholesterol a marker and therapeutic target for dyslipidemia in metabolic syndrome?

Vega GL.

Metab Syndr Relat Disord. 2014 Nov;12(9):451-3. doi: 10.1089/met.2014.1503. Epub 2014 Aug 19. No abstract available.

PMID:
25136896
16.

Association of multiple adiposity exposures and cardiorespiratory fitness with all-cause mortality in men: the Cooper Center Longitudinal Study.

Farrell SW, Finley CE, Jackson AW, Vega GL, Morrow JR Jr.

Mayo Clin Proc. 2014 Jun;89(6):772-80. doi: 10.1016/j.mayocp.2014.03.012. Epub 2014 May 5.

PMID:
24809758
17.

Association of urinary sodium-to-potassium ratio with obesity in a multiethnic cohort.

Jain N, Minhajuddin AT, Neeland IJ, Elsayed EF, Vega GL, Hedayati SS.

Am J Clin Nutr. 2014 May;99(5):992-8. doi: 10.3945/ajcn.113.077362. Epub 2014 Feb 19.

18.

Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men.

Vega GL, Barlow CE, Grundy SM, Leonard D, DeFina LF.

J Investig Med. 2014 Feb;62(2):345-9. doi: 10.2310/JIM.0000000000000044.

PMID:
24402298
19.

Ethnic and gender susceptibility to metabolic risk.

Grundy SM, Neeland IJ, Turer AT, Vega GL.

Metab Syndr Relat Disord. 2014 Mar;12(2):110-6. doi: 10.1089/met.2013.0113. Epub 2013 Dec 10.

20.

Relation of regional fat distribution to left ventricular structure and function.

Neeland IJ, Gupta S, Ayers CR, Turer AT, Rame JE, Das SR, Berry JD, Khera A, McGuire DK, Vega GL, Grundy SM, de Lemos JA, Drazner MH.

Circ Cardiovasc Imaging. 2013 Sep;6(5):800-7. doi: 10.1161/CIRCIMAGING.113.000532. Epub 2013 Aug 8.

21.

Waist circumference as measure of abdominal fat compartments.

Grundy SM, Neeland IJ, Turer AT, Vega GL.

J Obes. 2013;2013:454285. doi: 10.1155/2013/454285. Epub 2013 May 8.

22.

Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults.

Neeland IJ, Ayers CR, Rohatgi AK, Turer AT, Berry JD, Das SR, Vega GL, Khera A, McGuire DK, Grundy SM, de Lemos JA.

Obesity (Silver Spring). 2013 Sep;21(9):E439-47. doi: 10.1002/oby.20135. Epub 2013 May 19.

23.

LDL phenotype in subjects with mild cognitive impairment and Alzheimer's disease.

Vikarunnessa S, Weiner MF, Vega GL.

J Alzheimers Dis. 2013;36(3):571-5. doi: 10.3233/JAD-130443.

24.

Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile.

Neeland IJ, Winders BR, Ayers CR, Das SR, Chang AY, Berry JD, Khera A, McGuire DK, Vega GL, de Lemos JA, Turer AT.

J Am Coll Cardiol. 2013 Aug 20;62(8):752-60. doi: 10.1016/j.jacc.2013.03.038. Epub 2013 Apr 16.

25.

Metabolic risk susceptibility in men is partially related to adiponectin/leptin ratio.

Vega GL, Grundy SM.

J Obes. 2013;2013:409679. doi: 10.1155/2013/409679. Epub 2013 Mar 6.

26.

Relationship between perceptions about neighborhood environment and prevalent obesity: data from the Dallas Heart Study.

Powell-Wiley TM, Ayers CR, de Lemos JA, Lakoski SG, Vega GL, Grundy S, Das SR, Banks-Richard K, Albert MA.

Obesity (Silver Spring). 2013 Jan;21(1):E14-21. doi: 10.1002/oby.20012.

27.

Fasting glucose, obesity, and metabolic syndrome as predictors of type 2 diabetes: the Cooper Center Longitudinal Study.

DeFina LF, Vega GL, Leonard D, Grundy SM.

J Investig Med. 2012 Dec;60(8):1164-8. doi: 10.2310/JIM.0b013e318275656a.

PMID:
23111652
28.

Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults.

Neeland IJ, Turer AT, Ayers CR, Powell-Wiley TM, Vega GL, Farzaneh-Far R, Grundy SM, Khera A, McGuire DK, de Lemos JA.

JAMA. 2012 Sep 19;308(11):1150-9.

29.

Atherogenic low density lipoprotein phenotype in long-term survivors of childhood acute lymphoblastic leukemia.

Malhotra J, Tonorezos ES, Rozenberg M, Vega GL, Sklar CA, Chou J, Moskowitz CS, Eshelman-Kent DA, Janiszewski P, Ross R, Oeffinger KC.

J Lipid Res. 2012 Dec;53(12):2747-54. doi: 10.1194/jlr.P029785. Epub 2012 Sep 13.

30.

Influence of upper and lower body adipose tissue on insulin sensitivity in South Asian men.

Balakrishnan P, Grundy SM, Islam A, Dunn F, Vega GL.

J Investig Med. 2012 Oct;60(7):999-1004. doi: 10.2310/JIM.0b013e3182650a09.

PMID:
22914598
31.

Adiponectin as an independent predictor of the presence and degree of hepatic steatosis in the Dallas Heart Study.

Turer AT, Browning JD, Ayers CR, Das SR, Khera A, Vega GL, Grundy SM, Scherer PE.

J Clin Endocrinol Metab. 2012 Jun;97(6):E982-6. doi: 10.1210/jc.2011-3305. Epub 2012 Mar 21.

PMID:
22438228
32.

Cardiorespiratory fitness and metabolic risk.

Grundy SM, Barlow CE, Farrell SW, Vega GL, Haskell WL.

Am J Cardiol. 2012 Apr 1;109(7):988-93. doi: 10.1016/j.amjcard.2011.11.031. Epub 2012 Jan 3. Erratum in: Am J Cardiol. 2013 Jan 1;111(1):151.

PMID:
22221951
33.

Effect of colesevelam hydrochloride on glycemia and insulin sensitivity in men with the metabolic syndrome.

Vega GL, Dunn FL, Grundy SM.

Am J Cardiol. 2011 Oct 15;108(8):1129-35. doi: 10.1016/j.amjcard.2011.06.011. Epub 2011 Aug 1.

PMID:
21813109
34.

Adipose tissue mass and location affect circulating adiponectin levels.

Turer AT, Khera A, Ayers CR, Turer CB, Grundy SM, Vega GL, Scherer PE.

Diabetologia. 2011 Oct;54(10):2515-24. doi: 10.1007/s00125-011-2252-z. Epub 2011 Jul 22.

35.

Higher acute insulin response to glucose may determine greater free fatty acid clearance in African-American women.

Chow CC, Periwal V, Csako G, Ricks M, Courville AB, Miller BV 3rd, Vega GL, Sumner AE.

J Clin Endocrinol Metab. 2011 Aug;96(8):2456-63. doi: 10.1210/jc.2011-0532. Epub 2011 May 18.

36.

Comparisons of apolipoprotein B levels estimated by immunoassay, nuclear magnetic resonance, vertical auto profile, and non-high-density lipoprotein cholesterol in subjects with hypertriglyceridemia (SAFARI Trial).

Grundy SM, Vega GL, Tomassini JE, Tershakovec AM.

Am J Cardiol. 2011 Jul 1;108(1):40-6. doi: 10.1016/j.amjcard.2011.03.003. Epub 2011 May 10.

PMID:
21565322
37.

Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia.

Tonorezos ES, Vega GL, Sklar CA, Chou JF, Moskowitz CS, Mo Q, Church TS, Ross R, Janiszewski PM, Oeffinger KC.

Pediatr Blood Cancer. 2012 Jan;58(1):31-6. doi: 10.1002/pbc.22964. Epub 2011 Jan 19.

38.

Body size misperception: a novel determinant in the obesity epidemic.

Powell TM, de Lemos JA, Banks K, Ayers CR, Rohatgi A, Khera A, McGuire DK, Berry JD, Albert MA, Vega GL, Grundy SM, Das SR.

Arch Intern Med. 2010 Oct 11;170(18):1695-7. doi: 10.1001/archinternmed.2010.314. No abstract available.

39.

Is intra-abdominal obesity a unique risk factor for metabolic syndrome in non-diabetics?

Vega GL.

Indian J Med Res. 2010 May;131:603-5. No abstract available.

40.

Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers.

Serrano-Pozo A, Vega GL, L├╝tjohann D, Locascio JJ, Tennis MK, Deng A, Atri A, Hyman BT, Irizarry MC, Growdon JH.

Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):220-6. doi: 10.1097/WAD.0b013e3181d61fea.

41.

Prevalence of the metabolic syndrome as influenced by the measure of obesity employed.

Vega GL, Barlow CE, Grundy SM.

Am J Cardiol. 2010 May 1;105(9):1306-12. doi: 10.1016/j.amjcard.2009.12.048.

PMID:
20403484
42.

Indices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin.

Lakoski SG, Xu F, Vega GL, Grundy SM, Chandalia M, Lam C, Lowe RS, Stepanavage ME, Musliner TA, Cohen JC, Hobbs HH.

J Clin Endocrinol Metab. 2010 Feb;95(2):800-9. doi: 10.1210/jc.2009-1952. Epub 2009 Dec 4. Erratum in: J Clin Endocrinol Metab. 2011 May;96(5):1582.

43.

Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy.

Mehdi UF, Adams-Huet B, Raskin P, Vega GL, Toto RD.

J Am Soc Nephrol. 2009 Dec;20(12):2641-50. doi: 10.1681/ASN.2009070737. Epub 2009 Nov 19.

45.

Sex differences in the relationship between C-reactive protein and body fat.

Khera A, Vega GL, Das SR, Ayers C, McGuire DK, Grundy SM, de Lemos JA.

J Clin Endocrinol Metab. 2009 Sep;94(9):3251-8. doi: 10.1210/jc.2008-2406. Epub 2009 Jun 30.

46.

Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia.

Oeffinger KC, Adams-Huet B, Victor RG, Church TS, Snell PG, Dunn AL, Eshelman-Kent DA, Ross R, Janiszewski PM, Turoff AJ, Brooks S, Vega GL.

J Clin Oncol. 2009 Aug 1;27(22):3698-704. doi: 10.1200/JCO.2008.19.7251. Epub 2009 Jun 29.

47.

Impaired hepatic ketogenesis in moderately obese men with hypertriglyceridemia.

Vega GL, Dunn FL, Grundy SM.

J Investig Med. 2009 Apr;57(4):590-4. doi: 10.2310/JIM.0b013e31819e2f61.

PMID:
19342925
48.

Ethnic differences in hepatic steatosis: an insulin resistance paradox?

Guerrero R, Vega GL, Grundy SM, Browning JD.

Hepatology. 2009 Mar;49(3):791-801. doi: 10.1002/hep.22726.

49.

Closing comment.

Wilson PW, Vega GL.

J Clin Lipidol. 2008 Oct;2(5):397. doi: 10.1016/j.jacl.2008.08.450. Epub 2008 Aug 26. No abstract available.

PMID:
21291768
50.

Counterpoint: Lipoproteins and dementia: Is there compelling evidence to treat Alzheimer's patients with statins?

Wilson PW, Vega GL.

J Clin Lipidol. 2008 Oct;2(5):394-6. doi: 10.1016/j.jacl.2008.08.448. Epub 2008 Aug 26. No abstract available.

PMID:
21291766

Supplemental Content

Support Center